In patients with dyssynchronous heart failure (DHF), cardiac conduction abnormalities cause the regional distribution of myocardial work to be non-homogeneous. Cardiac resynchronization therapy (CRT) using an implantable, programmed biventricular pacemaker/defibrillator, can improve the synchrony of contraction between the right and left ventricles in DHF, resulting in reduced morbidity and mortality and increased quality of life. Since regional work depends on wall stress, which cannot be measured in patients, we used computational methods to investigate regional work distributions and their changes after CRT. We used three-dimensional multi-scale patient-specific computational models parameterized by anatomic, functional, hemodynamic, and electrophysiological measurements in eight patients with heart failure and left bundle branch block (LBBB) who received CRT. To increase clinical translatability, we also explored whether streamlined computational methods provide accurate estimates of regional myocardial work. We found that CRT increased global myocardial work efficiency with significant improvements in non-responders. Reverse ventricular remodeling after CRT was greatest in patients with the highest heterogeneity of regional work at baseline, however the efficacy of CRT was not related to the decrease in overall work heterogeneity or to the reduction in late-activated regions of high myocardial work. Rather, decreases in early-activated regions of myocardium performing negative myocardial work following CRT best explained patient variations in reverse remodeling. These findings were also observed when regional myocardial work was estimated using ventricular pressure as a surrogate for myocardial stress and changes in endocardial surface area as a surrogate for strain. These new findings suggest that CRT promotes reverse ventricular remodeling in human dyssynchronous heart failure by increasing regional myocardial work in early-activated regions of the ventricles, where dyssynchrony is specifically associated with hypoperfusion, late systolic stretch, and altered metabolic activity and that measurement of these changes can be performed using streamlined approaches., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Patent applications related to the technology described here have been submitted in the United States (“Compositions and methods for patient-specific modeling to predict outcomes of cardiac resynchronization therapy,” serial no. P00015-268P01; “Patient-specific modeling of ventricular activation pattern using surface ECG-derived vectorcardiogram in bundle branch block,” serial no. PCT/US15/36788). A.D.M and J.H.O are co-founders and equity-holders in Insilicomed, Inc., a licensee of UC San Diego software used in this research. A.D.M, C.T.V, and D.E.K. are co-founders and equity holders of Vektor Medical Inc., which was not involved in this research. Vektor Medical and Insilicomed, Inc. had no involvement at all in design, performance, analysis or funding of the present study. Vektor Medical and Insilicomed are licensees of intellectual property arising from or used in this research. This relationship has been disclosed to, reviewed, and approved by the University of California San Diego in accordance with its conflict of interest policies., (Copyright: © 2024 Craine et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)